These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 35320687)
21. E3 ligase ligand chemistries: from building blocks to protein degraders. Sosič I; Bricelj A; Steinebach C Chem Soc Rev; 2022 May; 51(9):3487-3534. PubMed ID: 35393989 [TBL] [Abstract][Full Text] [Related]
22. Lessons from natural molecular glue degraders. Cao S Biochem Soc Trans; 2024 Jun; 52(3):1191-1197. PubMed ID: 38864421 [TBL] [Abstract][Full Text] [Related]
23. Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic. Sasso JM; Tenchov R; Wang D; Johnson LS; Wang X; Zhou QA Biochemistry; 2023 Feb; 62(3):601-623. PubMed ID: 35856839 [TBL] [Abstract][Full Text] [Related]
24. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068 [TBL] [Abstract][Full Text] [Related]
25. Haven't got a glue: Protein surface variation for the design of molecular glue degraders. Kozicka Z; Thomä NH Cell Chem Biol; 2021 Jul; 28(7):1032-1047. PubMed ID: 33930325 [TBL] [Abstract][Full Text] [Related]
26. Clinical Translation of Targeted Protein Degraders. Kong NR; Jones LH Clin Pharmacol Ther; 2023 Sep; 114(3):558-568. PubMed ID: 37399310 [TBL] [Abstract][Full Text] [Related]
27. Crbn-based molecular Glues: Breakthroughs and perspectives. An J; Zhang X Bioorg Med Chem; 2024 Apr; 104():117683. PubMed ID: 38552596 [TBL] [Abstract][Full Text] [Related]
28. The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation. Riching KM; Caine EA; Urh M; Daniels DL Chem Soc Rev; 2022 Jul; 51(14):6210-6221. PubMed ID: 35792307 [TBL] [Abstract][Full Text] [Related]
29. Targeted protein degradation and the enzymology of degraders. Fisher SL; Phillips AJ Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948 [TBL] [Abstract][Full Text] [Related]
30. New Frontiers in the Discovery and Development of PROTACs. Barghout SH Anticancer Agents Med Chem; 2022 Aug; 22(15):2656-2661. PubMed ID: 35418290 [TBL] [Abstract][Full Text] [Related]
31. Mechanistic and Structural Features of PROTAC Ternary Complexes. Casement R; Bond A; Craigon C; Ciulli A Methods Mol Biol; 2021; 2365():79-113. PubMed ID: 34432240 [TBL] [Abstract][Full Text] [Related]
39. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles. Tao AJ; Gadbois GE; Buczynski SA; Ferguson FM Curr Opin Chem Biol; 2022 Apr; 67():102114. PubMed ID: 35042023 [TBL] [Abstract][Full Text] [Related]
40. Perspectives on the development of first-in-class protein degraders. Rambacher KM; Calabrese MF; Yamaguchi M Future Med Chem; 2021 Jul; 13(14):1203-1226. PubMed ID: 34015962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]